Samuel S. Engel

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

46h-index7.6kcitations193works4.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(128), Diabetes Management and Research(82), Metabolism, Diabetes, and Cancer(51), Pancreatic function and diabetes(21), Pharmacology and Obesity Treatment(17)

Publications176 total

Prevalence and characteristics of metabolic dysfunction-associated steatohepatitis among pediatric patients in the MarketScan Databases
UNC Libraries·2025Open Access
Prevalence and characteristics of metabolic dysfunction-associated steatohepatitis among pediatric patients in the MarketScan Databases
PLoS ONE·2025Open Access
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
Zeitschrift für Rheumatologie·2025· 1 cited
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
Zeitschrift für Rheumatologie·2025· 6 citedOpen Access
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK‐3655 in Individuals With Pre‐Cirrhotic MASH
Alimentary Pharmacology & Therapeutics·2025· 8 citedOpen Access
Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH
Journal of Hepatology·2024· 15 citedOpen Access
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction–associated steatotic liver disease
Hepatology·2024· 15 cited
The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
Canadian Journal of Gastroenterology and Hepatology·2024· 1 citedOpen Access
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
JHEP Reports·2023· 24 citedOpen Access
Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018
Annals of Hepatology·2023· 14 citedOpen Access
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
Journal of Hepatology·2023· 164 citedOpen Access
Long-term prognosis of patients with non-alcoholic fatty liver disease: a retrospective cohort study to understand the impact of surrogate disease end points on long-term outcomes in South Korea
Journal of Hepatology·2023
Long-term liver-related outcomes in 1,260 patients with non-cirrhotic NAFLD
Journal of Hepatology·2023
Predicting severe liver outcomes in NAFLD using repeated measurements of biomarkers—a cohort study in 1,260 patients
Journal of Hepatology·2023
A Phase 2a, randomized, active-comparator-controlled, open-label study to evaluate the efficacy and safety of efinopegdutide in individuals with non-alcoholic fatty liver disease
Journal of Hepatology·2023
Suboptimal adherence to food restrictions requirements related to drug regimens for chronic diseases
Current Medical Research and Opinion·2023
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
Pediatric Diabetes·2021· 28 cited
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
Pediatric Diabetes·2021· 29 cited
896-P: Demographic and Glycemic Parameters across Global Regions in Youth with T2D in Clinical Trials of Sitagliptin
Diabetes·2021
897-P: Demographic and Glycemic Parameters in Global Populations of Younger vs. Older Youth with T2D Randomized in Clinical Trials of Sitagliptin
Diabetes·2021
page 1 of 9Next →

Frequent Co-authors

Keith D. Kaufman(15), Gregory T. Golm(13), Larry Radican(8), Jeremy Johnson(7), Swapnil Rajpathak(6), Michael J. Davies(6), Barry J. Goldstein(6), Susan Huyck(6), Steven G. Terra(6), James P. Mancuso(6), Brett Lauring(6), Kimberly G. Brodovicz(6), Kristy Iglay(5), Saul Genuth(5), Rury R. Holman(5), Cynthia J. Girman(5), Edward A. O’Neill(5), Debora Williams‐Herman(4), Arti Bhan(4), Priscilla Hollander(4)